My goal is to provide high quality personalized healthcare that focuses on addressing the patient’s needs with regards to his/her illness. I find that it is important to listen to patients and their families in order to develop a care plan that meets their expectations.
Jaime Villanueva, MD
Critical Care, Pulmonary Medicine, Sleep Medicine
Practices In:
Winfield
Patients Seen:
Adults
Dr. Villanueva is currently a physician overseeing a clinical study for COPD. Learn more about clinical research and joining a study with Accellacare, today!
Back
Schedule an appointment with Jaime Villanueva, MD
A few questions to help guide us to a healthier happier you...
Already a Duly MyChart User?
Log in for a quicker scheduling journey.
Locations
Winfield
25 N. Winfield Road
Suite 300
Winfield, Illinois 60190
Board Certifications
Internal Medicine, Critical Care, Pulmonary Medicine, Sleep Medicine, Undersea and Hyperbaric Medicine
Languages
English, Spanish
Awards & Accolades
Medical Director, Hyperbaric Oxygen Therapy
2020
Medical Director, DMG Sleep Center
2020
Fellow of the Year, Pulmonary and Critical Care
2001
Margaret Rainford Hano Memorial Nephrology Award
1995
Clinical Interests
Obstructive sleep apnea, narcoplepsy, COPD, pulmonary nodules, asthma, hyperbaric oxygen therapy, medical evaluation for SCUBA diving
Memberships
American College of Chest Physicians
American Thoracic Society
American Academy of Sleep Medicine
Undersea and Hyperbaric Medicine Society
Edward Hospital
Northwestern Medicine Central DuPage Hospital
School
Loyola University
Stritch School of Medicine
Graduation Date:
1995
Degree:
MD
Residency
Loyola University Medical Center
Resident in Internal Medicine
Fellowships
Loyola University Medical Center
Provider's Contributions
Can’t Fall Asleep? It May Be Your Sleep Environment
Lifestyle & Wellness
October 2023
Provider’s Publications
Tired? You're Not Alone
October 2014
Save Your Life by Going to Sleep
July 2014
Provider’s Research
A 12-week Treatment, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Once Daily Indacaterol in Patients With Chronic Obstructive Pulmonary Disease
A multi-center, randomized, double-blind, 52-week study to assess the safety of QVA149 compared to QAB149 in patients with Chronic Obstructive Pulmonary Disease (COPD) who have moderate to severe airflow limitation
A randomised, active-controlled, double-blind, double-dummy, parallel group design, multi-center trial to compare the efficacy and safety of 2.5 μg and 5 μg Tiotropium Inhalation Solution delivered by the Respimat® Inhaler with Tiotropium inhalation
Study Evaluating the Efficacy, Safety, and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide, Formoterol Fumarate and Placebo for 24-Weeks in Patients With Mod to Severe COPD
Study to Compare the Efficacy and Safety of the Combination of Indacaterol 150 µg Once Daily With Open Label Tiotropium 18 µg Once Daily Vs. Open Label Tiotropium 18 µg Once Daily in Patients With Mod-to-severe Chronic Obstructive Pulmonary Disease
Study to Evaluate the Effect of Roflumilast 500 μg on Exacerbation Rate in Patients With COPD Treated With a Fixed-Dose Combination of Long Acting Beta Agonist and Inhaled Corticosteroid
Procedures
Bronchoscopy
Conditions
Asthma, COPD, Circadian Rhythm Disorders, Insomnia, Interstitial Lung Disease, Lung Cancer, Narcolepsy, Obstructive Sleep Apnea, Pulmonary Fibrosis, Restless Leg Syndrome, Sarcoidosis
Comments